百特国际(BAX)最主要的收入来源是什么？

通过最新财报数据拆解，该公司的收入主要由其核心业务板块与相关服务支持构成。您可以通过页面上的交互式图表直观查看各业务线对总营收的具体贡献比例。

如何直观分析 BAX 的财务状况与盈利模式？

瓜壳日历通过交互式桑基图(Sankey Diagram)和瀑布图(Waterfall Chart)，将该公司的总营收、销售成本、运营费用以及最终的净利润流程进行了全景可视化，方便投资者一分钟看懂其经营效率与现金流走向。

Income Statement Q1 2026
Item	Category	Value	YoY
Net sales	revenue	2.70B	2.90%
Other operating income (expense), net	revenue	42.00M	5.00%
Gross margin	profit	891.00M	3.48%
Cost of sales	cost	1.81B	2.61%
Aggregate	revenue	933.00M	3.55%
Income (loss) from continuing operations before income taxes	profit	6.00M	100.00%
Segment operating income	profit	66.00M	13.79%
Selling, general and administrative expenses	cost	728.00M	3.56%
Research and development expenses	cost	139.00M	-0.71%
Aggregate	revenue	72.00M
Interest income (expense), nonoperating	revenue	66.00M	3.12%
Other (income) expense, net	revenue	6.00M	100.00%

Business Breakdown
Segment	Value	YoY
Medical Products And Therapies	1.28B	1.82%
Healthcare Systems and Technologies	705.00M	0.14%
Pharmaceuticals	621.00M	6.88%
Others	90.00M	15.38%

Geography Breakdown
Segment	Value	YoY
UNITED STATES	1.44B	-3.69%
Non-US	1.27B	11.54%

Balance Sheet Q1 2026
Item	Category	Value
Inventories	assets	2.32B
Cash and cash equivalents	assets	2.02B
Accounts receivable, net of allowances of $67 in 2026 and $63 in 2025	assets	1.70B
Prepaid expenses and other current assets	assets	816.00M
Total current assets	assets	6.85B
Goodwill	assets	4.90B
Other intangible assets, net	assets	4.22B
Property, plant and equipment, net	assets	2.91B
Other non-current assets	assets	692.00M
Operating lease right-of-use assets	assets	277.00M
Total assets	assets	19.85B
Total liabilities	liabilities	13.83B
Noncontrolling interests	liabilities	27.00M
Total equity	liabilities	6.02B
Long-term debt and finance lease obligations, less current portion	liabilities	8.62B
Total current liabilities	liabilities	3.69B
Other non-current liabilities	liabilities	1.29B
Operating lease liabilities	liabilities	224.00M
Total baxter stockholders’ equity	equity	6.04B
Treasury stock, common, value	equity	10.74B
Accumulated other comprehensive loss	equity	3.80B
Accrued expenses and other current liabilities	liabilities	1.76B
Accounts payable	liabilities	1.09B
Current maturities of long-term debt and finance lease obligations	liabilities	842.00M
Aggregate	equity	20.58B
Retained earnings	equity	13.69B
Additional contributed capital	equity	6.21B
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2026 and 2025	equity	683.00M

Operating Activities – 3M 2026
Item	Value
Depreciation and amortization	237.00M
Cash flows from (used in) operations - continuing operations	213.00M
Increase (decrease) in accounts receivable	152.00M
Accounts payable	102.00M
Deferred income taxes	29.00M
Other noncash income (expense)	13.00M
Stock compensation	10.00M
Increase (decrease) in prepaid expense and other assets	2.00M
Net periodic pension and other postretirement costs	-4.00M
Other	-13.00M
Income (loss) from continuing operations	-17.00M
Increase (decrease) in inventories	-95.00M
Increase (decrease) in accrued expenses and other current liabilities	-203.00M

Investing Activities – 3M 2026
Item	Value
Payment for (proceeds from) other investing activity	4.00M
Cash flows from (used in) investing activities - continuing operations	-133.00M
Payments to acquire other productive assets	-137.00M

Financing Activities – 3M 2026
Item	Value
Proceeds from stock issued under employee benefit plans	8.00M
Payments of ordinary dividends, common stock	-5.00M
Other financing activities, net	-14.00M

Cash Balance – 3M 2026
Item	Value
Cash and cash equivalents, beginning of period	1.97B
Cash and cash equivalents, end of period	2.02B